Norman Payson - May 23, 2024 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
Director
Signature
/s/ Mark Livingston, Attorney-in-Fact
Stock symbol
PGNY
Transactions as of
May 23, 2024
Transactions value $
$0
Form type
4
Date filed
5/28/2024, 09:43 PM
Previous filing
May 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Award $0 +6.18K +78.53% $0.00 14K May 23, 2024 Direct F1
holding PGNY Common Stock 281K May 23, 2024 See footnote F2
holding PGNY Common Stock 122K May 23, 2024 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Stock Option (Right to Buy) Award $0 +24.1K $0.00 24.1K May 23, 2024 Common Stock 24.1K $27.15 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on May 23, 2025, subject to the Reporting Person's continued service on such date.
F2 The shares are held by The Norman C. and Melinda B. Payson Revocable Trust. Norman C. Payson and Melinda B. Payson are the trustees of the trust.
F3 These shares are held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over these shares.
F4 The shares subject to the option will vest on May 23, 2025, subject to the Reporting Person's continued service on such date.